# psoriasis - claude-opus-4-8

- Benchmark system: E2seq + Agent RAG
- Repeat: 7
- Task type: DISEASE-STATE
- Tissue / sample source: lesional skin
- Comparison or endpoint: psoriatic lesional skin versus normal control skin
- Answer input cohort: Discovery/Core only
- Selected items: 100
- Input fields: gene name, effect size (log2FC/HR), P value, FDR
- E2seq Agent RAG: enabled
- Conversation memory: disabled
- Thinking mode: disabled
- Held-out validation data in prompt/RAG: no
- Model API: Anthropic / claude-opus-4-8
- Message SHA-256: d1a33d3f606c81814c4fb94a6c63c8f1abebd3bde37d769e82eae4772d8ff873
- Response HTTP status: 200
- Prompt tokens: 20788
- Completion tokens: 6541
- Reasoning tokens: 0
- Total tokens: 27329
- API requests reported: 2
- Elapsed seconds: 215.281
- RAG status: reused_or_ready
- RAG records/genes reported: 100
- RAG elapsed seconds: 1150.303
- Question handoff seconds: 1163.566
- Final benchmark system: E2seq; file rank 5/5; original repeat 7; model vendor: Anthropic

---
# Multidimensional Interpretation of Psoriatic Lesional Skin Transcriptomics

## 1. Overall Biological Interpretation

The transcriptomic profile of psoriatic lesional skin reveals a coordinated hyperactivation of innate immune defense programs alongside profound epidermal barrier dysfunction. The data shows 90 upregulated and only 10 downregulated genes, reflecting a state of active inflammatory amplification rather than simple immune cell infiltration.

Three integrated biological themes emerge: (1) IL-17/IL-36 cytokine amplification loops driving keratinocyte activation, (2) antimicrobial peptide overproduction characteristic of barrier breach responses, and (3) aberrant epidermal differentiation with cornification program dysregulation. The magnitude of changes is striking—multiple antimicrobial genes show >10-fold upregulation (IL36A: log2FC=11.37; DEFB4A/4B: log2FC>11), suggesting these are not passenger responses but central pathogenic mechanisms.

Critically, the near-absence of downregulated genes and the loss of lipid metabolism markers (BTC: log2FC=-4.3; CYP2W1: log2FC=-4.7) indicate this is not a balanced inflammatory response but a state where normal epidermal homeostasis has been replaced by an alarm-state program locked in activation.

## 2. Core Biological Programs

### Program 1: IL-17/IL-36 Cytokine Amplification Network
**Direction:** Strongly upregulated  
**Major supporting genes:** IL36A (log2FC=11.37), IL36G (log2FC=5.68), IL19 (log2FC=7.58), IL20 (log2FC=5.67), IL36RN (upregulated), TNIP3 (log2FC=7.28)  
**Pathway:** IL-17 signaling pathway (KEGG); Cytokine-cytokine receptor interaction (KEGG)  

**Biological interpretation:**  
This program represents the master inflammatory amplification circuit in psoriasis. IL-36 cytokines (IL-36α, IL-36γ) are among the most dramatically upregulated genes in the dataset, and their coordinate elevation with IL-19 and IL-20 (both IL-10 family members that signal through shared receptors) creates a self-reinforcing keratinocyte activation loop. TNIP3, a negative regulator of NF-κB that paradoxically shows marked upregulation, likely reflects a failed feedback attempt to limit inflammation. The IL-36 receptor antagonist (IL36RN) is present but clearly insufficient to suppress signaling.

The network structure is critical here: IL-36 cytokines directly activate keratinocytes to produce more antimicrobial peptides, chemokines, and inflammatory mediators, which then recruit and activate immune cells that produce IL-17 and TNF-α, which in turn stimulate more IL-36 production. This represents a pathogenic feed-forward loop rather than a protective immune response.

**Evidence strength and limitations:**  
Very strong. Multiple independent cytokines within the same functional network show extreme and highly significant upregulation (all FDR<1e-80). KEGG pathway enrichment for IL-17 signaling and cytokine-receptor interaction directly supports this interpretation. The STRING network data confirms IL1RAP connections with IL-36 family members.

Limitation: The data cannot distinguish whether IL-36 overproduction is primary or secondary to other triggers. Additionally, protein-level validation and receptor occupancy data would strengthen the claim that these transcriptional changes translate to functional signaling.

### Program 2: Antimicrobial Peptide Hyperproduction and Host Defense Dysregulation
**Direction:** Massively upregulated  
**Major supporting genes:** DEFB4A (log2FC=11.18), DEFB4B (log2FC=11.03), DEFB103A (log2FC=5.76), DEFB103B (log2FC=5.75), S100A12 (log2FC=8.33), PI3 (log2FC=9.24)  
**Pathway:** Antimicrobial humoral response (GO:0019730); Staphylococcus aureus infection (KEGG)  

**Biological interpretation:**  
The coordinated extreme upregulation of multiple β-defensins (DEFB4A/4B showing the highest fold-changes in the entire dataset alongside IL-36A) and S100 alarm proteins indicates the epidermis is in a continuous alarm state characteristic of barrier breach. These antimicrobial peptides normally provide first-line defense against pathogens, but their overproduction in psoriasis creates a paradox: the skin behaves as if under microbial attack despite no active infection.

PI3 (elafin/SKALP), a protease inhibitor with antimicrobial properties showing 9.2 log2FC, is particularly informative because it's directly induced by IL-17 and IL-22 signaling. S100A12, a damage-associated molecular pattern (DAMP) molecule, can itself perpetuate inflammation by activating innate immune receptors. The KEGG enrichment for "Staphylococcus aureus infection" likely reflects pathway overlap rather than actual infection, but highlights that psoriatic skin expresses a gene program normally reserved for active microbial threats.

**Evidence strength and limitations:**  
Very strong. Four independent defensin genes plus multiple S100 family members all show extreme upregulation with exceptional statistical significance (FDR<1e-68). GO enrichment for antimicrobial humoral response and pathway analysis converge on this interpretation.

Limitation: Transcriptional upregulation does not prove that processed, bioactive peptide levels are proportionally elevated. Some antimicrobial peptides require proteolytic activation. The functional consequences of this antimicrobial peptide storm for the skin microbiome and whether it contributes to or protects against secondary infection in psoriasis remain incompletely resolved.

### Program 3: Epidermal Barrier Cornification Defects
**Direction:** Upregulated (aberrant pattern)  
**Major supporting genes:** SPRR2A (log2FC=7.31), SPRR2B (log2FC=6.38), SPRR2D (log2FC=5.92), SPRR2E (log2FC=3.99), SPRR3 (log2FC=7.18), LCE3A, LCE3D, KRT6A (log2FC=4.30)  
**Pathway:** Formation of the cornified envelope (Reactome R-HSA-6809371); Epidermis development (GO:0008544)  

**Biological interpretation:**  
This program reflects profound dysregulation of the epidermal differentiation program. Multiple small proline-rich proteins (SPRRs) and late cornified envelope (LCE) proteins show dramatic upregulation, and KRT6A (a stress-induced keratin) replaces normal differentiation keratins. Critically, this is not normal barrier formation—it represents an aberrant, inflammation-driven cornification program.

The Reactome pathway "Formation of the cornified envelope" includes 12 genes from this dataset, and the STRING network shows tight co-regulation among SPRR family members. This coherent upregulation suggests these genes are coordinately activated by shared transcription factors, likely AP-1 and NF-κB responding to inflammatory signals.

The biological consequence is the characteristic psoriatic scale: rapid, incomplete keratinocyte differentiation producing a thickened but functionally defective barrier. The paradox is that despite massive upregulation of structural barrier proteins, the barrier remains permeable and inflammatory—form without proper function.

**Evidence strength and limitations:**  
Strong. Multiple independent SPRR family members (SPRR2A/B/D/E, SPRR3) and LCE genes show coordinated, highly significant upregulation (all FDR<1e-69). Reactome pathway enrichment for cornified envelope formation directly supports this interpretation, and STRING network analysis confirms tight co-regulation.

Limitation: Upregulation of cornification genes does not prove proper protein cross-linking and functional barrier formation. The data cannot distinguish whether this aberrant differentiation program is a direct consequence of cytokine signaling or a compensatory response to barrier defects. Structural studies of the actual cornified envelope in psoriatic lesions would be needed to assess functional consequences.

### Program 4: Lipid and Metabolic Homeostasis Collapse
**Direction:** Downregulated  
**Major supporting genes:** BTC (log2FC=-4.30), CYP2W1 (log2FC=-4.70), plus metabolic context from KYNU (upregulated, log2FC=4.42), AKR1B10/AKR1B15 (upregulated, log2FC>5)  
**Pathway:** Response to lipopolysaccharide (GO:0032496, contextual); metabolic pathway components  

**Biological interpretation:**  
The downregulation of BTC (betacellulin, an EGFR ligand) and CYP2W1 (a cytochrome P450 involved in arachidonic acid metabolism) alongside the marked upregulation of enzymes like KYNU (kynurenine pathway) and AKR1B10/15 (aldo-keto reductases) indicates a fundamental metabolic reprogramming. 

BTC normally promotes keratinocyte proliferation and differentiation in a controlled manner; its suppression may reflect negative feedback from chronic hyperproliferation or disruption of normal growth factor signaling. CYP2W1's downregulation suggests altered lipid mediator metabolism, which could affect both barrier lipid composition and production of pro-resolving versus pro-inflammatory lipid mediators.

The elevation of KYNU is particularly interesting—this enzyme degrades tryptophan via the kynurenine pathway, which is activated by inflammatory cytokines (especially IFN-γ) and produces immunomodulatory metabolites. AKR1B10's dramatic upregulation (log2FC=6.27) may reflect altered retinoid and lipid aldehyde metabolism, both relevant to keratinocyte differentiation.

**Evidence strength and limitations:**  
Moderate. The interpretation rests on only a few downregulated genes (10 total in the dataset), though BTC and CYP2W1 are statistically robust (FDR<1e-73 and 1e-67 respectively). The upregulated metabolic enzymes are well-supported but their functional integration into a coherent "metabolic collapse" program requires inference.

Limitation: This is the most speculative of the five programs. The scarcity of downregulated genes limits network-level analysis. Metabolomic validation would be essential to confirm that these transcriptional changes translate to altered metabolite profiles and to assess whether metabolic changes are cause or consequence of the inflammatory program.

### Program 5: Keratinocyte Hyperproliferation and Acanthosis
**Direction:** Upregulated  
**Major supporting genes:** WNT5A (log2FC=2.53), FABP5 (log2FC=3.65), GJB2 (log2FC=4.42), GJB6 (log2FC=3.02), CDK5R1 (log2FC=2.35), HPSE (log2FC=2.92)  
**Pathway:** Epidermis development (GO:0008544); cellular component analysis shows cytoplasmic and membrane reorganization  

**Biological interpretation:**  
This program drives the epidermal hyperplasia (acanthosis) that characterizes psoriatic plaques. WNT5A, a non-canonical Wnt ligand, promotes keratinocyte proliferation and is directly induced by inflammatory cytokines. FABP5 (fatty acid binding protein 5) regulates lipid-driven signaling pathways including PPARβ/δ activation, which promotes proliferation and alters differentiation.

Gap junction proteins GJB2 (connexin 26) and GJB6 (connexin 30) show marked upregulation, reflecting altered intercellular communication in hyperplastic epidermis. Their dysregulation may contribute to abnormal keratinocyte coordination during differentiation. CDK5R1 (p35), a cyclin-dependent kinase activator, affects both cell cycle control and cytoskeletal organization.

HPSE (heparanase), an enzyme that degrades heparan sulfate in the extracellular matrix and basement membrane, may facilitate epidermal-dermal communication and inflammatory cell migration. Its upregulation could contribute to the architectural disorganization of psoriatic epidermis.

**Evidence strength and limitations:**  
Moderate to strong. Multiple genes supporting proliferation and tissue remodeling show significant upregulation (all FDR<1e-69), and the GO term for epidermis development includes many of these genes. However, the fold-changes are more modest (log2FC 2-4) compared to the inflammatory and antimicrobial programs, suggesting proliferation is a consequence rather than a primary driver.

Limitation: The proliferation program cannot be fully assessed from this data because classical proliferation markers (Ki67, PCNA, cyclins) are not represented in the top 100 genes. Immunohistochemical studies would be needed to quantify actual proliferation rates. The transcriptional signature may reflect steady-state hyperplasia rather than active proliferative burst.

---

## Summary

The psoriatic transcriptome reveals a pathological steady-state where inflammatory amplification (IL-36/IL-17 networks), antimicrobial alarm responses, and aberrant differentiation programs operate simultaneously and reinforce each other. The near-absence of counter-regulatory downregulation suggests failed negative feedback rather than balanced inflammation. The magnitude of changes in antimicrobial and cytokine genes exceeds what would be expected from secondary inflammation, supporting these as central pathogenic mechanisms rather than consequences.

The core limitation across all programs is that this is a single-timepoint transcriptional snapshot. It cannot distinguish initiating events from self-perpetuating consequences, and it cannot reveal whether interventions targeting specific programs (e.g., IL-36 blockade) would collapse the entire network or whether redundant pathways would compensate.

E2seq statistical audit: selected=100, ledger=100, RAG records=100, numeric claims checked=30, external claims checked=0, external mismatches=0, status=passed.

Answer model API: Anthropic / claude-opus-4-8

Source coverage (gene sources = selected items with records / selected RAG items; literature sources = articles / queries)
Online APIs: alliance 91/100 selected items (records returned); cbioportal 91/100 selected items (records returned); chembl 11/100 selected items (partially returned; some queries failed); civic 4/100 selected items (records returned); clinicaltrials 40/100 selected items (records returned); clinvar 90/100 selected items (records returned); ensembl 44/100 selected items (partially returned; some queries failed); europepmc 848 articles / initial full-cohort RAG 100 queries + 4 current-round queries; gtex 83/100 selected items (records returned); gwas 100/100 selected items (records returned); hpa 76/100 selected items (records returned); humanbase 100/100 selected items (records returned); intact 79/100 selected items (records returned); mygene 100/100 selected items (records returned); omnipath 36/100 selected items (records returned); opentargets 90/100 selected items (records returned); pubmed 669 articles / initial full-cohort RAG 100 queries + 3 current-round queries; quickgo 80/100 selected items (records returned); reactome 100/100 selected items (records returned); uniprot 80/100 selected items (records returned)
Local databases: gutmgene 2/100 selected items (records returned); hmdb 25/100 selected items (records returned); string 78/100 selected items (records returned); trrust 17/100 selected items (records returned)
